The group has extensive experience in the field of Neuropsychopharmacology, mainly in the following areas: i) Neurobiology of affective and schizophrenic spectrum disorders; ii) Mechanism of action of antidepressant and antipsychotic drugs; iii) Molecular mechanism underlying neuroprotection and neuroexcitotoxicity.


Professor Maurizio Popoli

Maurizio Popoli PI (M.P.) received postdoctoral training at Washington University Medical School (St. Louis, MO); he is a well-trained scientist with a 20-year experience in the study of signaling cascades (with particular emphasis on synaptic function) and of presynaptic mechanisms, and a 10-year experience in the study of molecular/cellular correlates of pathophysiology and drug treatment in neuropsychiatric disorders. He has published over 50 papers in international journals and served as referee for 15 Neuroscience and Neuropharmacology journals and Funding Associations. He has received national and international funding from governmental and non-profit agencies as well as by private companies. He recently (2002-2003) received an Independent Investigator Award from NARSAD (USA).

Professor Giorgio Racagni

Giorgio Racagni is full professor of Pharmacology, scientific director of the Center of Neuropharmacology (University of Milan), with about 300 papers and books published. He has held several managing positions in international scientific societies and is member of the WHO Expert Advisory Panel on Neurosciences.

Dr Daniela Tardito

Daniela Tardito has 7 years experience in preclinical research. During her doctoral training and thereafter she studied the involvement of signal transduction pathways, particularly the cAMP-PKA cascade and the CaM kinases signaling pathways in both pathophysiology of psychiatric disorders and mechanism of action of psychotropic drugs (in laboratory animals and peripheral cells from patients).